Ignite Creation Date:
2024-05-06 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05184491
Status:
UNKNOWN
Last Update Posted:
2022-01-11
First Post:
2021-11-13
Brief Title:
Nitazoxanide and Lansoprazole Based Regimens for H Pylori Management
Sponsor:
National Liver Institute Egypt
Organization:
National Liver Institute Egypt
Study Overview
Official Title:
Nitazoxanide and Lansoprazole Based Regimens for Managing Helicobacter Pylori in Egyptian Patients NILE Study
Status:
UNKNOWN
Status Verified Date:
2021-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NILE
Brief Summary:
The study will evaluate the eradication rate and tolerability of modified LOAD regimens three antibiotics and a proton pump inhibitor lansoprazole for management of HP infection in treatment-naive patients as well as patients who failed previous therapies
Detailed Description:
This will be randomized parallel group comparative open-label study that will be conducted to evaluate the efficacy and tolerability of a four-drug regimen modified LOAD regimen in eradicating HP The study will evaluate the efficacy of modified LOAD regimenslevofloxacinmoxifloxacin nitazoxanide doxycycline and lansoprazole inpatients who failed previous therapies and compare these regimens with the classic triple therapy amoxicillin clarithromycin and lansoprazole in treatment naïve patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None